Immunotherapeutic potential of whole tumour cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 7, p. 351, doi. 10.1007/s00262-002-0286-2
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2002 AND VI 51 AND IP 7
Results: 6
1
2
Protein A-induced apoptosis of cancer cells is effected by soluble immune mediators.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 7, p. 376, doi. 10.1007/s00262-002-0288-0
- By:
- Publication type:
- Article
3
Suppression of in vivo tumorigenicity of rat hepatoma cell line KDH-8 cells by soluble TGF-β receptor type II.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 7, p. 381, doi. 10.1007/s00262-002-0290-6
- By:
- Publication type:
- Article
4
Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 7, p. 367, doi. 10.1007/s00262-002-0295-1
- By:
- Publication type:
- Article
5
Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 7, p. 358, doi. 10.1007/s00262-002-0294-2
- By:
- Publication type:
- Article
6
Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 7, p. 389, doi. 10.1007/s00262-002-0296-0
- By:
- Publication type:
- Article